Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 526 | 325 | 337 | 276 | 588 |
| Gross Profit | 526 | 325 | 337 | 276 | 588 |
| Operating Expenses | 14,789 | 13,330 | 12,013 | 10,026 | 10,342 |
| Operating Income | -14,263 | -13,005 | -11,676 | -9,750 | -9,754 |
| Interest Expense | 23 | 29 | 24 | 14 | 26 |
| Other Income | 3,072 | 1,209 | 57 | 192 | 294 |
| Pre-tax Income | -11,214 | -11,825 | -11,643 | -9,572 | -9,486 |
| Net Income Continuous | -11,214 | -11,825 | -22,143 | -9,572 | -9,486 |
| Net Income Discontinuous | -490 | -459 | -5,183 | -784 | -1,620 |
| Net Income | $-11,704 | $-12,284 | $-24,675 | $-10,356 | $-11,106 |
| EPS Basic Total Ops | -0.18 | -0.25 | -0.97 | -0.37 | -0.40 |
| EPS Basic Continuous Ops | -0.17 | -0.24 | -0.82 | -0.34 | -0.34 |
| EPS Basic Discontinuous Ops | -0.01 | -0.01 | -0.15 | -0.03 | -0.06 |
| EPS Diluted Total Ops | -0.18 | -0.25 | -0.97 | -0.37 | -0.40 |
| EPS Diluted Continuous Ops | -0.17 | -0.24 | -0.82 | -0.34 | -0.34 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.01 | -0.15 | -0.03 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.20 | N/A | -0.40 | N/A |
| EBITDA(a) | $-13,691 | $-12,649 | $-11,430 | $-9,452 | $-9,501 |